Cann Group Ltd (ASX: CAN) is focused on breeding, cultivating and manufacturing medicinal cannabis for sale and use within Australia and internationally. The group formed research and cultivation facilities in Melbourne and is striving to offer access to medicinal cannabis for Australian patients. They got Australia’s first medicinal cannabis research license in February 2017, and first medicinal cannabis cultivation license in March 2017. Aurora Cannabis Inc – one of Canada’s largest listed medicinal cannabis companies – has 22.9% shareholding in the group. The group has set the cannabis operation based on its experience in the agriculture sector in terms of development and commercialization.